ANDA 75207, held by Pharmobedient. Fluoxetine Hydrochloride.
As of Nov 16, 2026, ANDA 75207 (Fluoxetine Hydrochloride), held by Pharmobedient, was first approved by FDA on Jan 30, 2002, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 2002 | Original application | Approved |
| Fluoxetine HydrochlorideEQ 10MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Fluoxetine HydrochlorideEQ 20MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Fluoxetine HydrochlorideEQ 40MG BASE · capsule;oral | Fluoxetine Hydrochloride | Discontinued |
| Jul 11, 2024 | Supplement 26Labeling · Standard review | Approved | None posted |
| Oct 29, 2019 | Supplement 24Labeling · Standard review | Approved | None posted |
| Jan 15, 2011 | Supplement 23Manufacturing | Approved | None posted |
| Dec 10, 2009 | Supplement 20Labeling | Approved | None posted |
| Jul 9, 2009 | Supplement 17Labeling | Approved | None posted |
| Feb 11, 2008 | Supplement 13Labeling | Approved | None posted |
| Feb 11, 2008 | Supplement 14Labeling | Approved | None posted |
| May 25, 2007 | Supplement 9Manufacturing | Approved | None posted |
| May 25, 2007 | Supplement 10Labeling | Tentative approval | None posted |
| Feb 22, 2007 | Supplement 11Labeling | Approved | None posted |
| Feb 22, 2007 | Supplement 12Labeling | Approved | None posted |
| Aug 17, 2006 | Supplement 6Labeling | Approved | None posted |
| Jan 31, 2006 | Supplement 5Labeling | Approved | None posted |
| Apr 22, 2005 | Supplement 3Labeling | Approved | None posted |
| Apr 22, 2005 | Supplement 4Labeling | Approved | None posted |
| Sep 13, 2004 | Supplement 2Labeling | Approved | None posted |
| Nov 14, 2003 | Supplement 1Labeling | Approved | None posted |
| Jan 30, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters